Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies

Several studies have confirmed α-synuclein real-time quaking-induced conversion (αSyn-RT-QuIC) assay to have high sensitivity and specificity for Parkinson’s disease. However, whether the assay can be used as a robust, quantitative measure to monitor disease progression, stratify different synuclein...

Full description

Bibliographic Details
Main Authors:	Poggiolini, I, Gupta, V, Lawton, M, Lee, S, El-Turabi, A, Querejeta-Coma, A, Trenkwalder, C, Sixel-Döring, F, Foubert-Samier, A, Le Traon, AP, Plazzi, G, Biscarini, F, Montplaisir, J, Gagnon, J-F, Postuma, RB, Antelmi, E, Meissner, WG, Mollenhauer, B, Ben-Shlomo, Y, Hu, MT, Parkkinen, L
Format:	Journal article
Language:	English
Published:	Oxford University Press 2021

Similar Items

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
by: Parkkinen, L, et al.
Published: (2016)

Investigating brain-derived α-synuclein fibrils and diagnostic biomarkers of synucleinopathies
by: Lee, S
Published: (2023)

LRP10 in α-synucleinopathies
by: Guerreiro, R, et al.
Published: (2018)

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder
by: Ouled Amar Bencheikh, B, et al.
Published: (2018)

Selective vulnerability in α-synucleinopathies.
by: Alegre-Abarrategui, J, et al.
Published: (2019)

The link between neuroinflammation and the neurovascular unit in synucleinopathies
by: Wang, Qing, et al.
Published: (2023)

Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease
by: Ruffmann, C, et al.
Published: (2018)

Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease
by: Hrabos, D, et al.
Published: (2024)

Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia
by: Parkkinen, L, et al.
Published: (2004)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
by: Sarkar, Souvarish, et al.
Published: (2021)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
by: Sarkar, Souvarish, et al.
Published: (2022)

Gut feelings about α-synuclein in gastrointestinal biopsies: biomarker in the making?
by: Ruffmann, C, et al.
Published: (2016)

From mechanisms to future therapy: a synopsis of isolated REM sleep behavior disorder as early synuclein-related disease
by: Stefani, A, et al.
Published: (2025)

Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
by: Parkkinen, L, et al.
Published: (2008)

Gut feeling about alpha-synuclein in gastro-intestinal biopsies: biomarker in the making?
by: Ruffmann, C, et al.
Published: (2015)

Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease
by: Parkkinen, L, et al.
Published: (2003)

Can olfactory bulb biopsy be justified for the diagnosis of Parkinson’s disease? Comments on “olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disorders”
by: Parkkinen, L, et al.
Published: (2008)

Widespread and abundant α-synuclein pathology in a neurologically unimpaired subject
by: Parkkinen, L, et al.
Published: (2005)

Relationship of Apolipoprotein E to Parkinson's disease-related alpha-synuclein pathology
by: Parkkinen, L, et al.
Published: (2013)

Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms
by: Parkkinen, L, et al.
Published: (2007)

Assessment of α-Synuclein Pathology
by: Alafuzoff, I, et al.
Published: (2008)

Colonic mucosal -synuclein lacks specificity as a biomarker for Parkinson disease
by: Ruffmann, C, et al.
Published: (2015)

Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
by: Doucet, M, et al.
Published: (2017)

Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
by: Tapiola, T, et al.
Published: (2009)

The significance of α-Synuclein, Amyloid-β and Tau pathologies in Parkinson's disease progression and related dementia
by: Compta, Y, et al.
Published: (2013)

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
by: Guella, I, et al.
Published: (2016)

Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2
by: Liekniņa, I, et al.
Published: (2024)

Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders
by: Altay, MF, et al.
Published: (2022)

Alpha-synuclein proximity ligation assay (AS-PLA) in brain sections to probe for alpha-synuclein oligomers
by: Roberts, RF, et al.
Published: (2019)

Explaining the Structural Plasticity of α-Synuclein
by: Ullman, Orly, et al.
Published: (2012)

Physiological and pathological properties of alpha-synuclein.
by: Tofaris, G, et al.
Published: (2007)

Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons
by: Zambon, F
Published: (2017)

Molecular mechanisms of cerebrospinal fluid production.
by: Brown, P, et al.
Published: (2004)

Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein.
by: Senior, S, et al.
Published: (2008)

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity
by: Brekk, OR, et al.
Published: (2020)

Optimisation of ExoCounter technology for use in cerebrospinal fluid and investigation of placenta-derived exosomes within cerebrospinal fluid
by: Davies, B
Published: (2023)

Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
by: Vaikath, N, et al.
Published: (2015)

Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages.
by: Haenseler, W, et al.
Published: (2017)

α-Synuclein and dopamine at the crossroads of Parkinson's disease.
by: Venda, L, et al.
Published: (2010)

Monitoring α-synuclein proteotoxicity in Drosophila models
by: Szabo, A, et al.
Published: (2019)